Clinical Trial Update: A Trial to Evaluate the Safety of Niraparib Tablets in Adult Female Participants With Advanced or Relapsed Epithelial Ovarian Cancer [Phase 4]

View source ↗

Summary

Phase 4 trial to evaluate the safety of Niraparib tablets in adult women with advanced or relapsed epithelial ovarian cancer; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Niraparib (Niraparib)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Ovarian Neoplasms | Phase 4 | Status: NOT_YET_RECRUITING